These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35481971)

  • 21. Cell-Free Circulating Methylated SEPT9 for Noninvasive Diagnosis and Monitoring of Colorectal Cancer.
    Fu B; Yan P; Zhang S; Lu Y; Pan L; Tang W; Chen S; Chen S; Zhang A; Liu W
    Dis Markers; 2018; 2018():6437104. PubMed ID: 29849824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylated septin 9 gene is an important prognostic marker in stage II and stage III colorectal cancer for evaluating local recurrence or distant metastasis after surgery.
    Huang M; He J; Lai W; Liu L; Xu H; Zeng Y; Lan Q; Lin X; Chu Z
    BMC Gastroenterol; 2022 Feb; 22(1):87. PubMed ID: 35227194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma-Methylated SEPT9 for the Noninvasive Diagnosis of Gastric Cancer.
    Zhao L; Li M; Zhang S; Liu Y
    J Clin Med; 2022 Oct; 11(21):. PubMed ID: 36362627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma Methylated SEPT9 as a Novel Biomarker for Predicting Liver Metastasis in Colorectal Cancer.
    Yu M; Yang C; Wang S; Shi Y; Wang J; Meng C; Xue L; Chen Z
    Mol Biotechnol; 2023 Aug; ():. PubMed ID: 37608077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating Methylated SEPT9 DNA Analyses to Predict Recurrence Risk and Adjuvant Chemotherapy Benefit in Stage II to III Colorectal Cancer.
    Yuan Z; Wang S; Ni K; Zhan Y; Ma H; Liu X; Xin R; Zhou X; Liu Z; Zhao X; Yin X; Ping H; Liu Y; Wang W; Yan S; Han Q; Cui W; Zhang X; Zhang Q; Zhang C
    Med Sci Monit; 2022 Sep; 28():e937757. PubMed ID: 36117308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of Plasma methylated SEPT9 for Predicting Microvascular Invasion and Tumor Proliferation in Hepatocellular Carcinoma.
    Huang F; Yang G; Jiang H; Chen X; Yang Y; Yu Q; Pan B; Wang B; Guo W; Yang W; Zhang C
    Technol Cancer Res Treat; 2022; 21():15330338221144510. PubMed ID: 36573042
    [No Abstract]   [Full Text] [Related]  

  • 27. The performance of the mSEPT9 assay is influenced by algorithm, cancer stage and age, but not sex and cancer location.
    Song L; Jia J; Yu H; Peng X; Xiao W; Gong Y; Zhou G; Han X; Li Y
    J Cancer Res Clin Oncol; 2017 Jun; 143(6):1093-1101. PubMed ID: 28224298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic Value of Methylated
    Xie L; Jiang X; Li Q; Sun Z; Quan W; Duan Y; Li D; Chen T
    Front Oncol; 2018; 8():247. PubMed ID: 30013949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of blood mSEPT9 in evaluating tumor burden and disease monitoring in colorectal cancer patients.
    Jiang H; Yu Q; Chen X; Zhang C; Shen J; Shen M; Yang Y; Wang B; Pan B; Guo W
    J Clin Lab Anal; 2021 Nov; 35(11):e24030. PubMed ID: 34591323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel microfluidic chip-based digital PCR method for enhanced sensitivity in the early diagnosis of colorectal cancer via mSEPT9.
    Huang Q; Xun Z; Lin J; Xie R; Zhu C; Wang L; Shang H; Wu S; Ou Q; Liu C
    Clin Chim Acta; 2024 Feb; 554():117781. PubMed ID: 38224929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of methylated SEPT9 in plasma is a reliable screening method for both left- and right-sided colon cancers.
    Tóth K; Sipos F; Kalmár A; Patai AV; Wichmann B; Stoehr R; Golcher H; Schellerer V; Tulassay Z; Molnár B
    PLoS One; 2012; 7(9):e46000. PubMed ID: 23049919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Value of plasma SEPTIN9 methylation detection for diagnosis and predicting radiosensitivity of esophageal carcinoma].
    Sun Q; Liu J; Fan X; Zhou Y; Wang X; Cui Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Aug; 41(8):1214-1219. PubMed ID: 34549713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood leukocytes methylation levels analysis indicate methylated plasma test is a promising tool for colorectal cancer early detection.
    Chen Z; Zhao G; Wang K; Wang X; Ma Y; Xiong S; Zheng M; Fei S
    J Cancer; 2021; 12(12):3678-3685. PubMed ID: 33995643
    [No Abstract]   [Full Text] [Related]  

  • 34.
    Li B; Huang H; Huang R; Zhang W; Zhou G; Wu Z; Lv C; Han X; Jiang L; Li Y; Li B; Zhang Z
    Dis Markers; 2020; 2020():6289063. PubMed ID: 33178361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Clinical Significance of Septin 9 and Colon Cancer Specific Antigen-2 (CCSA-2) in Colorectal Cancer.
    Abd El Kader L; Soliman AH; Salem SE; Akel SY; Ibrahim NH
    Asian Pac J Cancer Prev; 2023 Mar; 24(3):1027-1036. PubMed ID: 36974558
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Laven-Law G; Kichenadasse G; Young GP; Symonds EL; Winter JM
    Biomarkers; 2024 Jun; 29(4):194-204. PubMed ID: 38644767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of
    Sun J; Fei F; Zhang M; Li Y; Zhang X; Zhu S; Zhang S
    BMC Cancer; 2019 May; 19(1):450. PubMed ID: 31088406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A systematic review of the performance of the SEPT9 gene methylation assay in colorectal cancer screening, monitoring, diagnosis and prognosis.
    Song L; Yu H; Jia J; Li Y
    Cancer Biomark; 2017; 18(4):425-432. PubMed ID: 28128742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylated Septin9 (m
    Loomans-Kropp HA; Song Y; Gala M; Parikh AR; Van Seventer EE; Alvarez R; Hitchins MP; Shoemaker RH; Umar A
    Cancer Res Commun; 2022 Feb; 2(2):90-98. PubMed ID: 35992328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma levels of methylated septin 9 are capable of detecting hepatocellular carcinoma and hepatic cirrhosis.
    He N; Feng G; Zhang C; Wu F; Zhang T; Yang Y
    Mol Med Rep; 2020 Oct; 22(4):2705-2714. PubMed ID: 32945374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.